Gb Sciences Inc News Today

/PRNewswire/ -- The "Patient Recruitment and Retention Services Global Market Report 2023" report has been added to ResearchAndMarkets.coms offering. The...

The Parkinson's disease market is expected to grow to $12.8 billion by 2028. Brain Parkinsons Study LAS VEGAS, July 11, 2023 (Newswire.com) - Gb Sciences, Inc. (OTCQB:GBLX), a leading cannabis- and plant...

GB Sciences (OTCMKTS:GBLX – Free Report) is one of 394 publicly-traded companies in the “Biotechnology” industry, but how does it compare to its peers? We will compare GB Sciences to related companies based on the strength of its institutional ownership, valuation, analyst recommendations, earnings, profitability, dividends and risk. Profitability This table compares GB Sciences and […]

GB Sciences (OTCMKTS:GBLX – Free Report) is one of 385 public companies in the “Biotechnology” industry, but how does it compare to its rivals? We will compare GB Sciences to similar businesses based on the strength of its analyst recommendations, earnings, valuation, institutional ownership, profitability, risk and dividends. Profitability This table compares GB Sciences and […]

GB Sciences (OTCMKTS:GBLX – Get Rating) is one of 365 public companies in the “Biotechnology” industry, but how does it contrast to its peers? We will compare GB Sciences to similar companies based on the strength of its earnings, risk, dividends, valuation, institutional ownership, profitability and analyst recommendations. Profitability This table compares GB Sciences and […]

GB Sciences (OTCMKTS:GBLX – Get Rating) is one of 355 publicly-traded companies in the “Biotechnology” industry, but how does it contrast to its competitors? We will compare GB Sciences to related businesses based on the strength of its earnings, profitability, institutional ownership, dividends, risk, valuation and analyst recommendations. Valuation & Earnings This table compares GB […]

GB Sciences (OTCMKTS:GBLX – Get Rating) is one of 357 publicly-traded companies in the “Biotechnology” industry, but how does it weigh in compared to its peers? We will compare GB Sciences to similar businesses based on the strength of its risk, valuation, institutional ownership, profitability, earnings, dividends and analyst recommendations. Profitability This table compares GB […]

GB Sciences, Inc. (OTCMKTS:GBLX – Get Rating) was the target of a large increase in short interest in April. As of April 15th, there was short interest totalling 7,400 shares, an increase of 23.3% from the March 31st total of 6,000 shares. Based on an average daily volume of 600,300 shares, the days-to-cover ratio is […]

Biopharmaceutical research company specializing in cannabis- and plant-inspired medicines shares strategic plan for 2023 and key developments from 2022LAS VEGAS, NV / ACCESSWIRE / March 7, 2023 / Gb Sciences

12.12.2022 - As mental health disorders increasingly impact global populations, Gb Sciences is developing psychotropic but non-psychedelic treatments for anxiety and depression that compete with the emerging billion-dollar psychedelic companies.LAS VEGAS, Dec. ... Seite 1